针对细胞毒性T-淋巴细胞相关蛋白-4的未来:有没有作用?
Anna Maria Di Giacomo1, Michael Lahn2, Alexander Mm Eggermont3
1University of Siena, Siena, Italy; Center for Immuno-Oncology. University Hospital of Siena, Viale Bracci, 16, Siena, Italy; NIBIT Foundation Onlus, Italy.
European journal of cancer (Oxford, England : 1990)
|January 3, 2024
概括
向细胞毒性T淋巴细胞相关蛋白4 (CTLA-4) 提供持久的癌症免疫治疗反应. 研究重点是优化CTLA-4封锁和新疗法,以克服毒性和提高疗效.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 临床试验 临床试验
背景情况:
- 2022年NIBIT基金会智库会议召集专家讨论癌症免疫疗法.
- 重点是针对细胞毒性T淋巴细胞相关蛋白4 (CTLA-4) 的整合和扩展.
研究的目的:
- 评估在癌症治疗中针对CTLA-4的经验教训.
- 为了比较CTLA-4阻断与编程细胞死亡蛋白1 (PD1) 或其配体 (PDL1) 抑制.
- 探索基于CTLA-4的免疫疗法的未来策略.
主要方法:
- 在锡耶纳智库会议上进行专家讨论和达成共识.
- 对CTLA-4,PD1和PDL1抑制剂的临床经验的审查.
- 探索新的治疗方法和组合策略.
主要成果:
- 准CTLA-4可能会在显著的患者亚组中提供更持久的反应.
- 涉及CTLA-4和PD1/PDL1抑制剂的组合疗法正在研究中.
- 正在制定减轻CTLA-4阻塞毒性的策略,包括剂量调整和新药.
结论:
- 向CTLA-4仍然是提高癌症免疫疗法疗效的关键策略.
- 对CTLA-4机制和毒性管理的进一步研究是有必要的.
- 新的CTLA-4疗法承诺提高安全性和扩大组合选择.
相关概念视频
01:27Cytotoxic T Cells-mediated Immune Response
923
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
923
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K